What the company does
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic …
What the weekly tape is saying
BNTXN closed the latest completed week at 1,633 MXN. The 4-week return is 3.1% and the 12-week return is 12.1%. Trend Signal is inactive, Market Dynamics is -0.10. Setup signature: Risk-first tape with a 27/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,720 MXN
- Vs Trend Line
- -5.0%
- Fair Value
- 1,863 MXN
- Vs Fair Value
- -12.4%
- 52W High
- 2,100 MXN
- 52W Low
- 1,457 MXN
- Drawdown
- -22.2%
- Range Position
- 27.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- MX Healthcare
- Sector Rank
- 27 of 78
- Sector Percentile
- 66.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
MX Healthcare
- Tracked Peers
- 78
- 4W Rank
- 28 of 78
- Avg 1W
- -0.7%
- Avg 4W
- 0.4%
- Trend Breadth
- 19.2%
- Positive MD
- 29.5%
MX Biotechnology
- Tracked Peers
- 19
- 4W Rank
- 1 of 19
- Avg 1W
- -2.0%
- Avg 4W
- -7.2%
- Trend Breadth
- 15.8%
- Positive RS
- 10.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.10
- 4W MD Change
- 75.3%
- Relative Strength
- -16.11
- 4W RS Change
- 22.8%
- Expectation
- Negative
- Probability
- 31.58%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 310
- 52W Average
- 99
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.3%
- 52W Volatility
- 4.8%
- Upside Weeks
- 16
- Downside Weeks
- 15
- Downside Breadth
- 28.8%
- Avg Gain / Loss
- 4.0% / -5.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- MEX
- Country
- MX
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- MXN
- Market Cap
- 413.0B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,633 MXN | 0.0% | 1,720 MXN | 1,863 MXN | -0.10 | -16.11 | 0 | Off |
| 5 Jun 2026 | 1,633 MXN | 0.0% | 1,729 MXN | 1,865 MXN | -0.29 | -14.43 | 10 | Off |
| 29 May 2026 | 1,633 MXN | 3.1% | 1,737 MXN | 1,867 MXN | -0.32 | -18.26 | 3.8K | Off |
| 22 May 2026 | 1,584 MXN | 0.0% | 1,748 MXN | 1,868 MXN | -0.49 | -20.87 | 0 | Off |
| 15 May 2026 | 1,584 MXN | -8.4% | 1,760 MXN | 1,871 MXN | -0.42 | -20.86 | 35 | Off |
| 8 May 2026 | 1,729 MXN | -0.3% | 1,772 MXN | 1,872 MXN | -0.25 | -16.37 | 29 | Off |
| 1 May 2026 | 1,735 MXN | 0.0% | 1,777 MXN | 1,873 MXN | -0.23 | -14.10 | 0 | Off |
| 24 Apr 2026 | 1,735 MXN | 0.0% | 1,782 MXN | 1,874 MXN | -0.17 | -16.26 | 0 | Off |
| 17 Apr 2026 | 1,735 MXN | 8.5% | 1,784 MXN | 1,878 MXN | -0.31 | -17.41 | 64 | Off |
| 10 Apr 2026 | 1,599 MXN | -0.1% | 1,785 MXN | 1,882 MXN | -0.63 | -24.63 | 75 | Off |
| 3 Apr 2026 | 1,601 MXN | 9.9% | 1,791 MXN | 1,886 MXN | -0.69 | -24.86 | 44 | Off |
| 27 Mar 2026 | 1,457 MXN | 0.0% | 1,800 MXN | 1,891 MXN | -0.63 | -29.26 | 0 | Off |
| 20 Mar 2026 | 1,457 MXN | 0.0% | 1,814 MXN | 1,897 MXN | -0.12 | -27.17 | 0 | Off |
| 13 Mar 2026 | 1,457 MXN | -17.1% | 1,835 MXN | 1,903 MXN | 0.31 | -29.53 | 43 | Off |